(Q34234132)

31 July 2017

1 reference

title

Molecular piracy of Kaposi's sarcoma associated herpesvirus (English)

1 reference

31 July 2017

1 reference

Choi J

1

1 reference

31 July 2017

Means RE

series ordinal

2

1 reference

31 July 2017

Damania B

series ordinal

3

1 reference

31 July 2017

Jung JU

series ordinal

4

1 reference

31 July 2017

1 June 2001

1 reference

Cytokine and Growth Factor Reviews

31 July 2017

1 reference

31 July 2017

12

1 reference

31 July 2017

245-257

1 reference

31 July 2017

2-3

1 reference

The role of HHV-8 in Kaposi's sarcoma

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Perspective on Kaposi's sarcoma: facts, concepts, and conjectures

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Kaposi's sarcoma: is the hunt for the culprit over now?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Human herpesvirus 8: is it a tumor virus?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Kaposi's sarcoma (KS), KS-associated herpesvirus, and the criteria for causality in the age of molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Kaposi's sarcoma-associated herpesvirus.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Epstein-Barr virus and lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

EBV genes and B cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Burkitt's lymphoma and malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

The Epstein-Barr virus and its association with human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Periodic illness associated with Epstein-Barr virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Epstein-Barr virus infections in males with the X-linked lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

A region of the Herpesvirus saimiri genome required for oncogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

The divergence between two oncogenic Herpesvirus saimiri strains in a genomic region related to the transforming phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Construction of replication-competent Herpesvirus saimiri deletion mutants.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Deletion mutants of herpesvirus saimiri define an open reading frame necessary for transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Phenotypic and functional consequences of herpesvirus saimiri infection of human CD8+ cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Stable growth transformation of human T lymphocytes by herpesvirus saimiri

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

CD2-mediated autocrine growth of herpes virus saimiri-transformed human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Herpesvirus saimiri as a model for gammaherpesvirus oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Sequence and genomic analysis of a Rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

The primary sequence of rhesus monkey rhadinovirus isolate 26-95: sequence similarities to Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus isolate 17577

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Inhibition of intracellular transport of B cell antigen receptor complexes by Kaposi's sarcoma-associated herpesvirus K1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Retracted: Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Novel organizational features, captured cellular genes, and strain variability within the genome of KSHV/HHV8.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Structural basis of G protein-coupled receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

The N terminus of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor is necessary for high affinity chemokine binding but not for constitutive activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Viral encoded cyclins

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Cyclin encoded by KS herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Overcoming inhibitions: subversion of CKI function by viral cyclins.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

P27 in cell cycle control and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Chemokine-leukocyte interactions. The voodoo that they do so well

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Chemokines: leucocyte recruitment and activation cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

A broad spectrum secreted chemokine binding protein encoded by a herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Modulating chemokines: more lessons from viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Do viral chemokines modulate Kaposi's sarcoma?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Human herpes virus 8 interleukin-6 homologue triggers gp130 on neuronal and hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Viral strategies of immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Human cytomegalovirus inhibits antigen presentation by a sequential multistep process

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2800%2900029-0

7 January 2021

10.1016/S1359-6101(00)00029-0

Identifiers

DOI

1 reference

31 July 2017

1 reference